(Q64968472)

English

Irisin: a new potential hormonal target for the treatment of obesity and type 2 diabetes.

scientific article published in September 2012

In more languages

edit

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

22372821

retrieved

2 July 2019

reference URL

http://europepmc.org/abstract/MED/22372821

title

Irisin: a new potential hormonal target for the treatment of obesity and type 2 diabetes. (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

22372821

retrieved

2 July 2019

reference URL

http://europepmc.org/abstract/MED/22372821

1 reference

1 reference

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

22372821

retrieved

2 July 2019

reference URL

http://europepmc.org/abstract/MED/22372821

José Luis García-Giménez

series ordinal

5

1 reference

stated in

Europe PubMed Central

PubMed publication ID

22372821

retrieved

2 July 2019

reference URL

http://europepmc.org/abstract/MED/22372821

Giuseppe Lippi

series ordinal

2

object named as

Giuseppe Lippi

1 reference

stated in

Europe PubMed Central

PubMed publication ID

22372821

retrieved

2 July 2019

reference URL

http://europepmc.org/abstract/MED/22372821

author name string

Sara Mayero

series ordinal

3

1 reference

stated in

Europe PubMed Central

PubMed publication ID

22372821

retrieved

2 July 2019

reference URL

http://europepmc.org/abstract/MED/22372821

Carme Perez-Quilis

series ordinal

4

1 reference

stated in

Europe PubMed Central

PubMed publication ID

22372821

retrieved

2 July 2019

reference URL

http://europepmc.org/abstract/MED/22372821

publication date

1 September 2012

1 reference

stated in

Europe PubMed Central

PubMed publication ID

22372821

retrieved

2 July 2019

reference URL

http://europepmc.org/abstract/MED/22372821

published in

Journal of diabetes

1 reference

stated in

Europe PubMed Central

PubMed publication ID

22372821

retrieved

2 July 2019

reference URL

http://europepmc.org/abstract/MED/22372821

volume

4

1 reference

stated in

Europe PubMed Central

PubMed publication ID

22372821

retrieved

2 July 2019

reference URL

http://europepmc.org/abstract/MED/22372821

issue

3

1 reference

stated in

Europe PubMed Central

PubMed publication ID

22372821

retrieved

2 July 2019

reference URL

http://europepmc.org/abstract/MED/22372821

page(s)

196

1 reference

stated in

Europe PubMed Central

PubMed publication ID

22372821

retrieved

2 July 2019

reference URL

http://europepmc.org/abstract/MED/22372821

Identifiers

DOI

10.1111/J.1753-0407.2012.00194.X

1 reference

stated in

Europe PubMed Central

PubMed publication ID

22372821

retrieved

2 July 2019

reference URL

http://europepmc.org/abstract/MED/22372821

PubMed publication ID

22372821

1 reference

stated in

Europe PubMed Central

PubMed publication ID

22372821

retrieved

2 July 2019

reference URL

http://europepmc.org/abstract/MED/22372821

(Q64968472)

Irisin: a new potential hormonal target for the treatment of obesity and type 2 diabetes.

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)